Allos Therapeutics Appoints New President and CEO
Westminster-Colorado based Allos Therapeutics has appointed a new CEO and President. The firm said today that Paul L. Berns has joined the company as CEO, President, and as a member of the company's board of directors. Berns most recently served at Bone Care International. He has also held positions at Abbott Laboratories, BASF Pharmaceuticals, and Bristol-Myers Squibb. Allos is focused on developing and commercializing innovative small molecule therapeutics for the treatment of cancer.
posted on Friday, March 10, 2006
Related companies:
Allos Environmental, Inc.
Related stories:
> Rally Software Names Hudspeth CFO
> miRagen Therapeutics Gets $41M
> SiteOne Therapeutics Raises $15M
> Insys Therapeutics Files For IPO
> RemedyMD Appoints President, COO
Techrockies.com Home